rs903509

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_207122.2(EXT2):​c.2019-2890G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.902 in 152,220 control chromosomes in the GnomAD database, including 61,943 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.90 ( 61943 hom., cov: 31)

Consequence

EXT2
NM_207122.2 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.08

Publications

2 publications found
Variant links:
Genes affected
EXT2 (HGNC:3513): (exostosin glycosyltransferase 2) This gene encodes one of two glycosyltransferases involved in the chain elongation step of heparan sulfate biosynthesis. Mutations in this gene cause the type II form of multiple exostoses. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jul 2008]
EXT2 Gene-Disease associations (from GenCC):
  • exostoses, multiple, type 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics, G2P
  • seizures-scoliosis-macrocephaly syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • hereditary multiple osteochondromas
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_207122.2, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.967 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_207122.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EXT2
NM_207122.2
MANE Select
c.2019-2890G>A
intron
N/ANP_997005.1Q93063-1
EXT2
NM_000401.3
c.2118-2890G>A
intron
N/ANP_000392.3Q93063-3
EXT2
NM_001178083.3
c.2049-2890G>A
intron
N/ANP_001171554.1Q93063-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EXT2
ENST00000533608.7
TSL:1 MANE Select
c.2019-2890G>A
intron
N/AENSP00000431173.2Q93063-1
EXT2
ENST00000358681.8
TSL:1
c.2049-2890G>A
intron
N/AENSP00000351509.4Q93063-2
EXT2
ENST00000343631.4
TSL:1
c.2019-2890G>A
intron
N/AENSP00000342656.3Q93063-1

Frequencies

GnomAD3 genomes
AF:
0.902
AC:
137129
AN:
152102
Hom.:
61896
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.878
Gnomad AMI
AF:
0.979
Gnomad AMR
AF:
0.941
Gnomad ASJ
AF:
0.897
Gnomad EAS
AF:
0.990
Gnomad SAS
AF:
0.865
Gnomad FIN
AF:
0.912
Gnomad MID
AF:
0.892
Gnomad NFE
AF:
0.900
Gnomad OTH
AF:
0.912
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.902
AC:
137235
AN:
152220
Hom.:
61943
Cov.:
31
AF XY:
0.903
AC XY:
67174
AN XY:
74428
show subpopulations
African (AFR)
AF:
0.878
AC:
36456
AN:
41506
American (AMR)
AF:
0.941
AC:
14402
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.897
AC:
3111
AN:
3470
East Asian (EAS)
AF:
0.990
AC:
5130
AN:
5182
South Asian (SAS)
AF:
0.865
AC:
4157
AN:
4808
European-Finnish (FIN)
AF:
0.912
AC:
9676
AN:
10606
Middle Eastern (MID)
AF:
0.898
AC:
264
AN:
294
European-Non Finnish (NFE)
AF:
0.900
AC:
61222
AN:
68028
Other (OTH)
AF:
0.913
AC:
1924
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
695
1391
2086
2782
3477
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
906
1812
2718
3624
4530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.894
Hom.:
5943
Bravo
AF:
0.906
Asia WGS
AF:
0.942
AC:
3275
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.96
CADD
Benign
2.1
DANN
Benign
0.54
PhyloP100
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs903509;
hg19: chr11-44262809;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.